Abstract
The signal transducer and activator of transcription (STAT) 3 is essential for mediating signals from the receptors for a variety of cytokines and growth factors, including IL-6 and EGF, and from cytoplasmic tyrosine kinases. Upon stimulation, STAT3 is phosphorylated at Ser727 and Tyr705. However, the role of phosphorylation at Ser727, and the kinase pathways responsible for this phosphorylation in IL-6 signaling remain obscure. Here we show that IL-6 activates at least two distinct STAT3 serine kinase pathways and that an H7-sensitive pathway is dominant over a PD98059-sensitive one in HepG2 cells stimulated with a low concentration of IL-6. The analysis, using a series of chimeric receptors containing the extracellular domain of the G-CSF receptor, the truncated form of gp 130, and additional short peptides at the gp 130 carboxy-terminus, showed that the YXXQ motif of gp 130 was sufficient for the H7-sensitive STAT3 Ser727 phosphorylation. This YXXQ-mediated pathway does not involve Erk, p38, JNK, or PKCĪ“, and requires a site in the region from 533 to 711 of STAT3 for phosphorylation in vivo. Moreover, we show that Ser727 is required for full transcriptional activity of STAT3 for two different response elements. Thus, the YXXQ motif regulates STAT3 activities in two ways in response to even a low concentration of IL-6: it recruits STAT3 to the receptor for tyrosine phosphorylation, and activates an unidentified H7-sensitive pathway leading to the serine phosphorylation of STAT3.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T . 1994 Cell 77: 63ā71
Beadling C, Ng J, Babbage JW, Cantrell DA . 1996 EMBO J. 15: 1902ā1913
Boccaccio C, Ando M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio PM . 1998 Nature 391: 285ā288
Boulton TG, Stahl N, Yancopoulos GD . 1994 J. Biol. Chem. 269: 11648ā11655
Boulton TG, Zhong Z, Wen Z, Darnell Jr JE, Stahl N, Yancopoulos GD . 1995 Proc. Natl. Acad. Sci. USA 92: 6915ā6919
Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell Jr JE . 1996 Proc. Natl. Acad. Sci. USA 93: 7673ā7678
Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell Jr JE . 1998 Mol. Cell Biol. 18: 2553ā2558
Chakraborty A, Dyer KF, Cascio M, Mietzner TA, Tweardy DJ . 1999 Blood 93: 15ā24
Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, Pine R, O'Shea JJ . 1996 J. Immunol. 157: 4781ā4789
Chung J, Uchida E, Grammer TC, Blenis J . 1997 Mol. Cell Biol. 17: 6508ā6516
Coffer P, Lutticken C, van Pujenbroek A, Klop-de JM, Horn F, Kruijer W . 1995 Oncogene 10: 985ā994
Darnell Jr JE, Kerr IM, Stark GR . 1994 Science 264: 1415ā1421
Fujitani Y, Nakajima K, Kojima H, Nakae K, Takeda T, Hirano T . 1994 Biochem. Biophys. Res. Commun. 202: 1181ā1187
Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T . 1996 Immunity 5: 449ā460
Greenlund AC, Farrar MA, Viviano BL, Schreiber RD . 1994 EMBO J. 13: 1591ā1600
Hirano T, Nakajima K, Hibi M . 1997 Cytokine Growth Factor Rev. 8: 241ā252
Horvath CM, Darnell Jr JE . 1996 J. Virol. 70: 647ā650
Ichiba M, Nakajima K, Yamanaka Y, Kiuchi N, Hirano T . 1998 J. Biol. Chem. 273: 6132ā6138
Ihara S, Nakajima K, Fukada T, Hibi M, Nagata S, Hirano T, Fukui Y . 1997 EMBO J. 16: 5345ā5352
Jain N, Zhang T, Fong SL, Lim CP, Cao X . 1998 Oncogene 17: 3157ā3167
Jain N, Zhang T, Kee WH, Li W, Cao X . 1999 J. Biol. Chem. 274: 24392ā24400
Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M, Hirano T . 1999 J. Exp. Med. 189: 63ā73
Kojima H, Nakajima K, Hirano T . 1996 Oncogene 12: 547ā554
Lim CP, Cao X . 1999 J. Biol. Chem. 274: 31055ā31061
LĆ¼tticken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Yasukawa K, Taga T, Kishimoto T, Barbieri G, Pellegrini S, Sendtues M, Heinrich PC, Horn F . 1994 Science 263: 89ā92
LĆ¼tticken C, Coffer P, Yuan J, Schwartz C, Caldenhoven E, Schindler C, Kruijer W, Heinrich PC, Horn F . 1995 FEBS Lett. 360: 137ā143
Matsuda T, Hirano T, Kishimoto T . 1988 Eur. J. Immunol. 18: 951ā956
Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S . 1996 Proc. Natl. Acad. Sci. USA 93: 3963ā3966
Nakajima K, Wall R . 1991 Mol. Cell. Biol. 11: 1409ā1418
Nakajima K, Kusafuka T, Takeda T, Fujitani Y, Nakae K, Hirano T . 1993 Mol. Cell. Biol. 13: 3027ā3041
Nakajima K, Matsuda T, Fujitani Y., Kojima H, Yamanaka Y, Nakae K, Takeda T, Hirano T . 1995 Interleukin-6-type cytokines, Vol. 762. Mackiewicz A, Koj A and Sehgal PB. (eds). Annals of the New York Academy of Sciences: New York pp.ā55ā70
Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M, Hirano T . 1996 EMBO J. 15: 3651ā3658
Narimatsu M, Nakajima K, Ichiba M, Hirano T . 1997 Biochem. Biophys. Res. Commun. 238: 764ā768
O'Farrell AM, Parry DA, Zindy F, Roussel MF, Lees E, Moore KW, Mui AL . 2000 J. Immunol. 164: 4607ā4615
Schaefer LK, Wang S, Schaefer TS . 1999 Biochem. Biophys. Res. Commun. 266: 481ā487
Schuringa JJ, Jonk LJ, Dokter WH, Vellenga E, Kruijer W . 2000 Biochem. J. 347: 89ā96
Sengupta TK, Talbot ES, Scherle PA, Ivashkiv LB . 1998 Proc. Natl. Acad. Sci. USA 95: 11107ā11112
Shirogane T, Fukada T, Muller JM, Shima DT, Hibi M, Hirano T . 1999 Immunity 11: 709ā719
Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, Ihle JN, Yancopoulos GD . 1994 Science 263: 92ā95
Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell Jr JE, Yancopoulos GD . 1995 Science 267: 1349ā1353
Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM . 1994 Mol. Pharmacol. 46: 840ā850
Takahashi-Tezuka M, Yoshida Y, Fukada T, Ohtani T, Yamanaka Y, Nishida K, Nakajima K, Hibi M, Hirano T . 1998 Mol. Cell Biol. 18: 4109ā4117
Taniguchi T . 1995 Science 2688: 251ā255
Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S, Jove R . 1999 Mol. Cell Biol. 19: 7519ā7528
Uddin S, Fish EN, Sher DA, Gardziola C, White MF, Platanias LC . 1997 J. Immunol. 158: 2390ā2397
Wegenka UM, Buschmann J, LĆ¼tticken C, Heinrich PC, Horn F . 1993 Mol. Cell Biol. 13: 276ā288
Wen Z, Zhong Z, Darnell Jr JE . 1995 Cell 82: 241ā250
Wen Z, Darnell Jr JE . 1997 Nucleic Acids Res. 25: 2062ā2067
Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T . 1996 EMBO J 15: 1557ā1565
Yokogami K, Wakisaka S, Avruch J, Reeves SA . 2000 Curr. Biol. 10: 47ā50
Yuan J, Wegenka UM, LĆ¼tticken C, Buschmann J, Decker T, Schindler C, Heinrich PC, Horn F . 1994 Mol. Cell Biol. 14: 1657ā1668
Zhang JJ, Zhao Y, Chait BT, Lathem WW, Ritzi M, Knippers R, Darnell Jr JE . 1998 EMBO J 17: 6963ā6971
Zhang X, Blenis J, Li HC, Schindler C, Chen KS . 1995 Science 267: 1990ā1994
Zhong Z, Wen Z, Darnell Jr JE . 1994 Science 264: 95ā98
Zhu X, Wen Z, Xu LZ, Darnell Jr JE . 1997 Mol. Cell Biol. 17: 6618ā6623
Acknowledgements
We thank Shigemi Kinoshita and Garry Nolan for help with the retrovirus transfection system and Toshio Kitamura for the gift of the pMX retrovirus vector. This work was supported in part by Grants from the Ministry of Education, Science, Sports and Culture in Japan, the Special Coordination Fund from the Science and Technology Agency of the Japanese Government, the Osaka Foundation for Promotion of Clinical Immunology, the Ryoichi Naito Foundation for Medical Research, the Takeda Science Foundation, and the Mochida Memorial Foundation for Medical and Pharmaceutical Research.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abe, K., Hirai, M., Mizuno, K. et al. The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway. Oncogene 20, 3464ā3474 (2001). https://doi.org/10.1038/sj.onc.1204461
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204461
Keywords
This article is cited by
-
Molecular characterization and expression analysis of the putative interleukin 6 receptor (IL-6RĪ± and glycoprotein-130) in rainbow trout (Oncorhynchus mykiss): Salmonid IL-6RĪ± possesses a polymorphic N-terminal Ig domain with variable numbers of two repeats
Immunogenetics (2012)
-
STAT3 and cardiac remodeling
Heart Failure Reviews (2011)
-
Anti-inflammatory effect of insulin in the human hepatoma cell line HepG2 involves decreased transcription of IL-6 target genes and nuclear exclusion of FOXO1
Molecular and Cellular Biochemistry (2011)
-
Protein kinase C-Ī“ is involved in the inflammatory effect of IL-6 in mouse adipose cells
Diabetologia (2010)
-
Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways
Oncogene (2003)